Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Lakefront Biotherapeutics NV/ 6-K

SEC Filing · 6-K

Lakefront Biotherapeutics NV

SEC Filing

Filed Sep 23, 2026Accepted Sep 22, 2026, 7:06 PM EDTCIK 1421876Accession 0001171843-26-006176
View company →Permanent SEC source ↗
Share

Company context

Current securities

GLPGFOTC · EQUITY · CurrentLKFTNASDAQ · ADR · Current

Recent company filings

  1. 6-K filingSep 15, 2026
  2. 6-K filingSep 8, 2026
  3. 6-K filingSep 8, 2026
  4. 6-K filingSep 1, 2026
  5. 6-K filingAug 25, 2026

As-filed source

Primary evidence
As filedOpen full document ↗